Optimising antibacterial utilisation in Argentine intensive care units: a quality improvement collaborative
Facundo Jorro-Baron,Cecilia Inés Loudet,Wanda Cornistein,Inés Suarez-Anzorena,Pilar Arias-Lopez,Carina Balasini,Laura Cabana,Eleonora Cunto,Pablo Rodrigo Jorge Corral,Luz Gibbons,Marina Guglielmino,Gabriela Izzo,Marianela Lescano,Claudia Meregalli,Cristina Orlandi,Fernando Perre,Maria Elena Ratto,Mariano Rivet,Ana Paula Rodriguez,Viviana Monica Rodriguez,Jacqueline Vilca Becerra,Paula Romina Villegas,Emilse Vitar,Javier Roberti,Ezequiel García-Elorrio,COST Collaborative Group,Viviana Rodriguez,Natalí Ini,Juan Pedro Alonso,Marisol García Sarubbio,Agustina Paglia,María Cecilia García,Silvia Laura Fernández,Olga Zulema Tejerina,Cristian Efrain Tejerina,Dalma Fabian,Aylén Gutierrez,Julián Vercellone,Susana Noemi Tejerina,Viviana Chediack,María Julieta Ochoa,Cintia Hernaiz,Cecilia Domínguez,Alicia Sirino,Cecilia Del Valle Barrios,Ana Valeria Lugo,Flavia Nitto,Fernando Luna,Laura Valeria Aldana,María Fernanda FormigaFresser,Ainoa Echegoyen,Nelson Linares,Luciano Inowlocki Calejman,Mariana Casas Alvarez,Johnny Rodríguez Galán,Graciela Farfan,Luz Torrico García,Eva Rodríguez Caicedo,Verónica Bortoli,Eliseo Velasquez Chambi,Vanesa Arce Villanueva,Eduardo Zamora Mendizabal,Gustavo Figueroa Ojeda,Ángeles Rodríguez Altamirano,Ytala Talamas Hurtado,Carlos Gustavo RuizPulgar,Edson Gozales Aguilar,Carla Daniela BautistaNumbela,Lilia Elisa Müller,Virginia Soledad Quiroga
DOI: https://doi.org/10.1136/bmjqs-2024-017069
2024-08-15
Abstract:Background: There is limited evidence from antimicrobial stewardship programmes in less-resourced settings. This study aimed to improve the quality of antibacterial prescriptions by mitigating overuse and promoting the use of narrow-spectrum agents in intensive care units (ICUs) in a middle-income country. Methods: We established a quality improvement collaborative (QIC) model involving nine Argentine ICUs over 11 months with a 16-week baseline period (BP) and a 32-week implementation period (IP). Our intervention package included audits and feedback on antibacterial use, facility-specific treatment guidelines, antibacterial timeouts, pharmacy-based interventions and education. The intervention was delivered in two learning sessions with three action periods along with coaching support and basic quality improvement training. Results: We included 912 patients, 357 in BP and 555 in IP. The latter had higher APACHE II (17 (95% CI: 12 to 21) vs 15 (95% CI: 11 to 20), p=0.036), SOFA scores (6 (95% CI: 4 to 9) vs 5 (95% CI: 3 to 8), p=0.006), renal failure (41.6% vs 33.1%, p=0.009), sepsis (36.1% vs 31.6%, p<0.001) and septic shock (40.0% vs 33.8%, p<0.001). The days of antibacterial therapy (DOT) were similar between the groups (change in the slope from BP to IP 28.1 (95% CI: -17.4 to 73.5), p=0.2405). There were no differences in the antibacterial defined daily dose (DDD) between the groups (change in the slope from BP to IP 43.9, (95% CI: -12.3 to 100.0), p=0.1413).The rate of antibacterial de-escalation based on microbiological culture was higher during the IP (62.0% vs 45.3%, p<0.001).The infection prevention control (IPC) assessment framework was increased in eight ICUs. Conclusion: Implementing an antimicrobial stewardship program in ICUs in a middle-income country via a QIC demonstrated success in improving antibacterial de-escalation based on microbiological culture results, but not on DOT or DDD. In addition, eight out of nine ICUs improved their IPC Assessment Framework Score.